EXAGEN INC. - COMMON STOCK

Exagen Inc. to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

17 Nov 2021 15:05:00 By Nasdaq GlobeNewswire

Exagen Inc. Reports Third Quarter 2021 Results

10 Nov 2021 15:05:01 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum

04 Nov 2021 15:05:01 By Nasdaq GlobeNewswire

Exagen to Announce Third Quarter 2021 Financial Results on November 10, 2021

27 Oct 2021 15:05:01 By Nasdaq GlobeNewswire

Exagen Inc. Expands Coverage with Inland Empire Health Plan, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE Lupus

27 Oct 2021 07:25:00 By Nasdaq GlobeNewswire

Exagen Inc. Announces $27.2 Million Debt Refinancing

25 Oct 2021 07:25:00 By Nasdaq GlobeNewswire

Exagen Showcases Eight Scientific Presentations at ACR’s Virtual Annual Meeting in November 2021

21 Oct 2021 15:05:00 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference

13 Sep 2021 15:15:00 By Nasdaq GlobeNewswire

Exagen Inc. Reports Second Quarter 2021 Results

09 Aug 2021 15:05:01 By Nasdaq GlobeNewswire

Exagen Appoints Ana Hooker to Board of Directors

30 Jul 2021 07:25:00 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in the Canaccord Genuity 41st Annual Growth Conference

29 Jul 2021 07:25:00 By Nasdaq GlobeNewswire

Exagen to Announce Second Quarter 2021 Financial Results on August 9, 2021

26 Jul 2021 15:05:56 By Nasdaq GlobeNewswire

AVISE® Lupus Test Demonstrates Statistically Significant Clinical Utility in Achieving a Definitive SLE Diagnosis and Positively Impacts Treatment Decisions

13 Jul 2021 15:05:00 By Nasdaq GlobeNewswire

Exagen Elects Frank Stokes to Board of Directors

18 Jun 2021 07:29:00 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in the William Blair 41st Annual Growth Stock Conference

24 May 2021 15:05:00 By Nasdaq GlobeNewswire

Exagen Inc. Reports First Quarter 2021 Results

11 May 2021 15:05:01 By Nasdaq GlobeNewswire

Exagen Inc., Allegheny Health Network Research Institute and AHN Autoimmunity Institute Announce Collaboration to Develop Novel Patented Biomarkers into Clinical Diagnostic Tests

04 May 2021 15:05:00 By Nasdaq GlobeNewswire

Exagen Announces New Campaign and Initiatives for Lupus Awareness Month

03 May 2021 07:25:00 By Nasdaq GlobeNewswire

Exagen to Announce First Quarter 2021 Financial Results on May 11, 2021

27 Apr 2021 15:05:01 By Nasdaq GlobeNewswire

Exagen Inc. Announces Study on the Long-Term Effects of COVID-19 Infection in the Development of Autoimmune Diseases

29 Mar 2021 07:25:00 By Nasdaq GlobeNewswire